ENTRY       D08469                      Drug
NAME        Rasagiline (USAN/INN);
            Azilect (TN)
FORMULA     C12H13N
EXACT_MASS  171.1048
MOL_WEIGHT  171.2383
CLASS       Neuropsychiatric agent
             DG01568  MAO inhibitor
              DG01512  Monoamine oxidase B inhibitor
             DG01967  Antiparkinson agent
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
REMARK      ATC code: N04BD02
            Chemical structure group: DG00865
            Product (DG00865): D02562<JP/US>
EFFICACY    Antiparkinsonian, Neuroprotectant, Monoamine oxidase B (MAO-B) inhibitor
COMMENT     Treatment of Parkinson's disease
TARGET      MAOB [HSA:4129] [KO:K00274]
  PATHWAY   hsa04726(4129)  Serotonergic synapse
            hsa04728(4129)  Dopaminergic synapse
METABOLISM  Enzyme: CYP1A2 [HSA:1544]
INTERACTION  
STR_MAP     map07027  Antidepressants
            map07057  Antiparkinsonian agents
            map07216  Catecholamine transferase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N04 ANTI-PARKINSON DRUGS
               N04B DOPAMINERGIC AGENTS
                N04BD Monoamine oxidase B inhibitors
                 N04BD02 Rasagiline
                  D08469  Rasagiline (USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01568  MAO inhibitor
               DG01512  Monoamine oxidase B inhibitor
                DG00865  Rasagiline
                 D08469  Rasagiline
              DG01967  Antiparkinson agent
               DG00865  Rasagiline
                D08469  Rasagiline
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00865  Rasagiline
                D08469  Rasagiline
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Amine oxidases
                MAOB
                 D08469  Rasagiline (USAN/INN)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D08469
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08469
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01568  MAO inhibitor
               DG01512  Monoamine oxidase B inhibitor
                DG00865  Rasagiline
              DG01967  Antiparkinson agent
               DG00865  Rasagiline
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00865  Rasagiline
DBLINKS     CAS: 136236-51-6
            PubChem: 96025155
            ChEBI: 63620
            PDB-CCD: RAU
            LigandBox: D08469
            NIKKAJI: J573.894F
ATOM        13
            1   C8y C    22.8900  -17.7100
            2   C8y C    22.8900  -16.3100
            3   C8x C    21.7000  -15.6100
            4   C8x C    20.5100  -16.3100
            5   C8x C    20.5100  -17.7100
            6   C8x C    21.7000  -18.4100
            7   C1y C    24.2200  -18.1300
            8   C1x C    25.0600  -17.0100
            9   C1x C    24.2200  -15.8200
            10  N1b N    24.2200  -19.5300
            11  C1b C    25.4800  -20.2300
            12  C3b C    26.6700  -19.5300
            13  C3a C    27.8600  -18.8300
BOND        14
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 1
            9     8   9 1
            10    2   9 1
            11    7  10 1 #Up
            12   10  11 1
            13   11  12 1
            14   12  13 3
///
